Partnering Solutions

1. Real World Evidence 5/10/2019

   Implementing an enterprise-wide Real World Evidence strategy is essential to meet the growing demands of regulators, patients, healthcare providers and payers to support approval, treatment decisions and reimbursement. Fluency in evidence-generation combined with operational expertise in RWE are crucial for capitalizing on the potential RWE has to offer.

2. Methodology For Quality Pharma-Focused Market Research 4/7/2020

   Download the brochure to learn how ISR finds and screens quality respondents, what sets their market research apart, and how their custom reports can be specifically tailored to meet your company’s needs.

3. Oncology Site Network 1/2/2020

   Investigative sites are the centerpiece of a successful clinical trial, but more often than not, sites are treated like a third spoke in a wheel. At Catalyst, we place a high value on the partnerships our sites and other study collaborators bring to ensure a successful clinical trial, resulting in new terapies for those battling cancer.

4. The CNS Challenge: Balancing Risk With Reward 9/10/2020

   Founded by a team of neuroscientists, Worldwide has worked in CNS since the late 1970s when the first cholinesterase inhibitors emerged as a cognitive therapeutic. Our breadth and depth of experience continues more than 40 years later, as we continue to innovate and adapt in our commitment to advancing research.

5. Clinical Monitoring Oversight 5/25/2021

   The hard truth is: Clinical Oversight is essential — and required. Ensuring that your trial is delivered with the highest of quality, on time, and on budget is essential with the escalating costs to conduct clinical trials and to avoid unnecessary and often required, change orders.

6. Providing Uncommon Expertise For Your Oncology Program 6/11/2020

   Worldwide Clinical Trials' award-winning, specialized early phase oncology team helps emerging and established biopharma, biotech, and pharmaceutical companies accelerate the advancement of early phase compounds through clinical testing.

7. Real World Evidence/Real World Data 5/10/2019

   Regulator and payer constituencies have recognized the immense potential of real world evidence (RWE) in accelerating our ability to answer important questions about the safety and effectiveness of medical treatments. The opportunity to capitalize on RWD/RWE goes beyond the regulatory domain. Payer demand for evidence to support a product’s value proposition is growing, in part due to proliferation of value-based reimbursement models. In addition, the 21st Century Cures Act mandates that FDA explore the use of RWE to expand indications for approved drugs and to fulfill post approval requirements.

8. How Biorasi Optimizes Clinical Solutions 4/26/2019

   Best-in-class processes coupled with industry-leading technology to fight for your trial’s success.

9. Medrio For Boutique CROs 9/22/2021

   Medrio’s integrated eSuite is flexible and intuitive so you can execute on bids efficiently while increasing build speed, data quality, and sponsor trust.

10. Are You Working With An Ideal CRO? 6/26/2020

    Making the right choice when engaging a CRO promptly sets you up for optimal efficiency through the course of your study and best results at completion. We want you to feel confident in reaching that initial decision to work with us. To determine how we stack up against your goals and resource capacity, we’ve assembled a checklist of criteria you need from your ideal CRO partner.